Peginterferon alfa-2b (Xiamen Amoytop Biotech)

聚乙二醇干扰素α-2b （厦门特宝生物）

Report date: 2026/05/22 20:01:29

Base Information

Drug NamePeginterferon alfa-2b (Xiamen Amoytop Biotech)
Drug Alias Name干扰素α-2bY-shaped pegylated interferon alfa-2bY型PEG化重组人干扰素α 2bYpeginterferon alpha-2bYpeginterferon alfa-2b +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsThrombocythemia, EssentialHepatitis C, ChronicHepatitis C +[6] 
Global Approved IndicationsHepatitis CHepatitis B
Approved Indications in ChinaHepatitis CHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date2016/09/02
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesXiamen Amoytop Biotech Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesXiamen Amoytop Biotech Co Ltd
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Xiamen Bosai Gene Transcription Technology Co Ltd
Active IndicationsThrombocythemia, EssentialHepatitis CHepatitis B, Chronic +[4] 
Inactive IndicationsHepatitis C, ChronicHIV Infections

Other Information

ATC CodeL03AB10
Related LinksN/A